In light of the hardships caused by the pandemic, the Finance Ministry had issued a press release on 25 June 2021 stating that amounts received by any person for medical treatment of Covid- 19 (including amounts received for the treatment of family members) would be tax-exempt. The press release further stated that ex-gratia payments received by family members on the death of any person due to Covid-19 would also be tax-exempt up to specified limits. If the ex-gratia payment is made by the employer of the deceased person, the entire amount would be tax-exempt. However, for payments received from other persons, the amount of exemption would be INR 10 lakh in aggregate. Legislative amendments for these exemptions were to be proposed in due course.
In this backdrop, the Finance Bill, 2022 (Bill) has proposed certain amendments to the Income Tax Act, 1961 (ITA) discussed below.
The Bill proposes to exclude from the definition of ‘perquisite’ any sum paid by the employer for any expenditure actually incurred by the employee on medical treatment or that of any family member for any illness relating to Covid-19. Therefore, such amounts would not be taxed as salary income in the hands of the recipient-employee.
Similarly, any sum of money received by an individual from any other person for any expenditure incurred on medical treatment or the treatment of any family member for any illness related to Covid-19 would not be taxed as ‘other income’ in the hands of the recipient.
Download PDF to read moreIf you would like to receive content directly in your inbox from our knowledge repository, please complete this subscription form. This service is reserved for clients and eligible contacts.
This page contains general information regarding Trilegal and is not intended as a solicitation or an advertisement of its services or any invitation or inducement of any sort. Nothing contained in this website constitutes legal advice or creation of a lawyer-client relationship. If you have any issues, you must seek legal advice. Trilegal is not liable for the consequences of any action taken by relying on the material/information provided on this website. For more information, please read our terms of use and our privacy policy.